Radiotherapy and combined modality approaches in localised prostate cancer.
Dearnaley
D P
DP
The Institute of Cancer Research and The Royal Marsden NHS Trust, Academic Unit of Radiotherapy, Sutton, Surrey, UK.
D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D020266:Radiotherapy, Conformal / Q000379:methods
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal